Trials / Completed
CompletedNCT01466348
Effects of a Common Cold Treatment on Cognitive Function
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A reduction in alertness and lower levels of performance are commonly associated with the common cold. Paracetamol has been shown to be more effective than placebo in treating symptoms associated with upper respiratory tract infection; caffeine has been shown to increase levels of alertness and improve performance of people suffering from colds. This study will investigate any improvement in alertness and performance based on cognitive function and mood assessment in subjects suffering from the common cold, when taking a novel paracetamol and caffeine combination verses paracetamol alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paracetamol and Caffeine | Paracetamol 1000 mg and caffeine 130 mg |
| DRUG | Paracetamol | Paracetamol 1000 mg |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2011-11-07
- Last updated
- 2013-11-25
- Results posted
- 2013-11-25
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01466348. Inclusion in this directory is not an endorsement.